Genetics studies have a diversity problem that researchers struggle to fix

The FDA on Tues­day grant­ed Mer­ck pri­or­i­ty re­view for its in­ves­ti­ga­tion­al pneu­mo­coc­cal vac­cine, mak­ing strides ahead of Pfiz­er in the com­pa­nies’ years­long con­test atop the

John­son & John­son re­leased more da­ta and im­ages as part of its pro­gram to di­ver­si­fy the re­search and ed­u­ca­tion­al ma­te­r­i­al avail­able in der­ma­to­log­i­cal con­di­tions, part